BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23608308)

  • 1. A rare case of gastric Crohn's disease associated with immune thrombocytopenic purpura.
    Shaaban H; Maroules M
    J Crohns Colitis; 2013 Oct; 7(9):e401-2. PubMed ID: 23608308
    [No Abstract]   [Full Text] [Related]  

  • 2. [A case of Crohn's disease that shows the improvement of the gastric disorder by the administration of mesalazine powder].
    Nagamata H; Torii A; Izumi M; Anami M; Yamashita N; Inadama E; Toda G
    Nihon Shokakibyo Gakkai Zasshi; 2000 Oct; 97(10):1261-6. PubMed ID: 11075590
    [No Abstract]   [Full Text] [Related]  

  • 3. Education and imaging. Gastrointestinal: gastric Crohn's disease.
    Tseng TC; Chang YT; Wong JM
    J Gastroenterol Hepatol; 2007 Oct; 22(10):1690. PubMed ID: 17845696
    [No Abstract]   [Full Text] [Related]  

  • 4. Idiopathic thrombocytopenic purpura associated with Crohn's disease.
    Baudard M; Molina T; Benfiguig K; Bethoux JP; Zittoun R
    Haematologica; 1998 Jan; 83(1):92-3. PubMed ID: 9542329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic thrombocytopenic purpura and pancytopenia in a patient with Crohn's disease: a new association.
    Manzano ML; Yela C; Castellano G; Rodriguez S; Solis JA
    Am J Gastroenterol; 1996 Aug; 91(8):1678-9. PubMed ID: 8759706
    [No Abstract]   [Full Text] [Related]  

  • 6. Crohn's disease associated with severe autoimmune thrombocytopenic purpura.
    Tsibouris P; Kapsoritakis AN; Bouronikou E; Boulbou M; Kyriakou D; Potamianos SP
    Inflamm Bowel Dis; 2006 Dec; 12(12):1188-9. PubMed ID: 17119395
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe exudative ascites as an initial presentation of Crohn's disease.
    Tekin F; Vatansever S; Ozütemiz O; Musoğlu A; Ilter T
    Turk J Gastroenterol; 2005 Sep; 16(3):171-3. PubMed ID: 16245232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presentation of Crohn's disease as metastatic cutaneous non-caseating granulomatous lesions.
    Delgado J; Delgado B; Sztarkier I; Cagnano E; Sperber AD; Fich A
    Isr Med Assoc J; 2003 Dec; 5(12):897-8. PubMed ID: 14689766
    [No Abstract]   [Full Text] [Related]  

  • 9. Mesalamine derivatives in the treatment of Crohn's disease.
    Harrell LE; Hanauer SB
    Gastroenterol Clin North Am; 2004 Jun; 33(2):303-17, ix-x. PubMed ID: 15177540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Improved treatment of Crohn's disease].
    Nau JY
    Rev Med Suisse; 2005 May; 1(18):1241. PubMed ID: 15977716
    [No Abstract]   [Full Text] [Related]  

  • 11. You're the flight surgeon. Crohn's disease.
    Hartwich SA
    Aviat Space Environ Med; 2004 Aug; 75(8):716-7. PubMed ID: 15328792
    [No Abstract]   [Full Text] [Related]  

  • 12. Mesalamine in the treatment of active Crohn's disease.
    Dignass A; Marteau P
    Gastroenterology; 2005 Jan; 128(1):245-6; author reply 246. PubMed ID: 15633152
    [No Abstract]   [Full Text] [Related]  

  • 13. Mesalamine maintenance therapy for Crohn's disease.
    Feagan BG; McDonald JW
    Gastroenterology; 2001 Feb; 120(2):585-6. PubMed ID: 11271451
    [No Abstract]   [Full Text] [Related]  

  • 14. Crohn's disease and secondary amyloidosis: early complication? A case report and review of the literature.
    Basturk T; Ozagari A; Ozturk T; Kusaslan R; Unsal A
    J Ren Care; 2009 Sep; 35(3):147-50. PubMed ID: 19689697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Co-existence of Crohn's disease and primary immune thrombocytopenia and its implications in treatment].
    Crespo Madrid N; Ruiz Hernández C; Giraldo Escobar L; Pujol Muncunill G; Martín de Carpi J
    An Pediatr (Barc); 2015 Dec; 83(6):433-5. PubMed ID: 26432762
    [No Abstract]   [Full Text] [Related]  

  • 16. Obstructing Crohn's disease of the duodenum: is surgery always mandatory?
    Karaoglu AO; Yukselen V
    Int J Clin Pract; 2004 Feb; 58(2):221-3. PubMed ID: 15055874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease.
    Feagan BG
    Eur J Surg; 1998 Dec; 164(12):903-9. PubMed ID: 10029385
    [No Abstract]   [Full Text] [Related]  

  • 18. Mesalamine and relapse prevention in Crohn's disease.
    Cottone M; Cammà C
    Gastroenterology; 2000 Aug; 119(2):597. PubMed ID: 10960274
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group.
    Thomsen OO; Cortot A; Jewell D; Wright JP; Winter T; Veloso FT; Vatn M; Persson T; Pettersson E
    N Engl J Med; 1998 Aug; 339(6):370-4. PubMed ID: 9691103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of glomerulonephritis early in the course of Crohn's disease.
    Koçak E; Köklü S; Akbal E; Huddam B; Azak A; Yilmaz SR
    Inflamm Bowel Dis; 2010 Apr; 16(4):548-9. PubMed ID: 19637383
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.